We asked Daniel Cohen from Spark Therapeutics and Kassi Stein from Tessera Therapeutics about how their work impacts specific clinical outcomes, key improvements they have seen in the landscape, and how students can get involved right out of graduate school. You can access the full recording by becoming an ACS BIOT member today here!
